Clinical Trial Update: TEPH: Telaglenastat Efficacy in Pulmonary Hypertension [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes planned evaluation of telaglenastat (CB-839) for efficacy in pulmonary hypertension in Phase 1/2, with the study not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Telaglenastat (CB-839) (telaglenastat)

Snippet

Sponsor: Chan, Stephen, MD, PhD | Conditions: Pulmonary Hypertension | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING